AbbVie Bolsters Inflammatory Disease Portfolio with Celsius Therapeutics Acquisition
AbbVie (NYSE: ABBV), a major U.S. pharmaceutical company, has announced the acquisition of Celsius Therapeutics...
Deals
Novo Nordisk Moves to Acquire 2seventy bio’s Hemophilia A Program and Gene-Editing Technology
Novo Nordisk (NYSE: NVO; CPH: NOVO-B), a leading Danish biopharmaceutical company, is transitioning from a...
China’s Kingfriend Biochemical Acquires U.S.-Listed Adalimumab Biosimilar Yusimry for USD 40 Million
Nanjing Kingfriend Biochemical Pharmaceutical Co., Ltd (SHA: 603707), a Chinese pharmaceutical company, has announced the...
Shanghai Kehua Bioengineering’s Subsidiary to Acquire Remaining Stake in Technogenetics S.P.A.
Shanghai Kehua Bioengineering Co., Ltd (SHE: 002022), a Chinese bioengineering company, has announced that its...
GenScript Biotech Receives Over USD 410 Million in Milestone Payments for CAR-T Therapy from Janssen Biotech
GenScript Biotech Corporation (HKG: 1548), a Contract Research Organization (CRO) based in China, has announced...
Jianke.com, China’s Leading Chronic Disease Management Platform, Files for Hong Kong IPO
Jianke.com, a China-based smart healthcare service platform, has filed for an initial public offering (IPO)...
TowardPi Medical Secures RMB 200 Million in Series D Financing Led by Matrix Partners
TowardPi (Beijing) Medical Technology Ltd, a Chinese medical technology company, has reportedly secured RMB 200...
Amoy Diagnostics Partners with Servier to Develop Companion Diagnostic Reagent for IDH Mutations in China
China-based Amoy Diagnostics Co., Ltd (AmoyDx, SHE: 300685) has entered into a partnership with French...
Shanghai’s Phrontline Biopharma Secures Over RMB 100 Million in Pre-Series A Funding for ADC Development
Shanghai-based antibody drug conjugate (ADC) specialist Phrontline Biopharma has reportedly secured over RMB 100 million...
Revvity and Sanyou Biopharmaceuticals Deepen Partnership to Advance Biologic Drug Development
Shanghai-based biotechnology company Revvity has entered into a comprehensive partnership with Sanyou Biopharmaceuticals Co., Ltd...
CASI Pharmaceuticals Secures USD 15 Million in PIPE Transaction for Anti-CD38 Monoclonal Antibody Development
CASI Pharmaceuticals (NASDAQ: CASI), a biopharmaceutical company based in China, has announced the signing of...
Sanofi Invites Bids Starting at $20 Billion for Consumer Health Unit
Sanofi (NYSE: SNY) is reportedly inviting bids starting at USD 20 billion for its consumer...
Eli Lilly & Co. Partners with OpenAI to Use Generative AI in Antimicrobial Drug Discovery
Eli Lilly & Co. (NYSE: LLY), a leading pharmaceutical company based in the U.S., has...
Aidea Pharmaceutical to Boost Stake in Nanda Pharmaceutical to 51.1256%
Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488), a pharmaceutical company based in China, is poised...
Walvax Biotechnology Halts COVID-19 mRNA Vaccine Trials Co-Developed with Abogen Biosciences
Walvax Biotechnology Co., Ltd (SHE: 300142), a biopharmaceutical company based in China, has announced the...
Suzhou Porton Biologics Becomes First Chinese CDMO to Adopt MaxCyte’s ExPERT GTx Platform
Suzhou Porton Biologics Ltd, a biopharmaceutical company based in China, has announced the introduction of...
Jiangsu Jibeier Pharm Completes Private Placement to Fund R&D Center on STAR Market
Jiangsu Jibeier Pharm Co., Ltd (SHA: 688566), a Chinese pharmaceutical company, has announced the successful...
Tonghua Dongbao Pharmaceuticals Partners with Sinopharm for Supply Chain and Market Expansion
Tonghua Dongbao Pharmaceuticals (SHA: 600867), a Chinese pharmaceutical company, has entered into a strategic partnership...
Fosun Pharma to Take Henlius Private in Deal Valued at HKD 5.407 Billion
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced plans to take...
Sun Yat-sen University and KingMed Diagnostics Collaborate on Talent Development and Research
On June 20, 2024, the School of Public Health (Shenzhen) of Sun Yat-sen University and...